Lassa Virus Replicon Particle Vaccine Protects Strain 13/N Guinea Pigs Against Challenge With Geographically and Genetically Diverse Viral Strains
Journal Article
·
· Journal of Infectious Diseases
Abstract
Lassa virus (LASV) causes mild to severe hemorrhagic fever disease in humans. Strain 13/N guinea pigs are highly susceptible to infection with LASV strain Josiah (clade IV), providing a critical model system for therapeutics and vaccine development. To develop additional models of disease, we detail the clinical course in guinea pigs infected with 5 geographically and genetically diverse LASV strains. Two of the developed models (LASV clades II and III) were then used to evaluate efficacy of a virus replicon particle vaccine against heterologous LASV challenge, demonstrating complete protection against clinical disease after a single vaccination dose.
- Research Organization:
- Oak Ridge Institute for Science and Education (ORISE), Oak Ridge, TN (United States)
- Sponsoring Organization:
- USDOE Office of Science (SC)
- DOE Contract Number:
- SC0014664
- OSTI ID:
- 2425727
- Journal Information:
- Journal of Infectious Diseases, Journal Name: Journal of Infectious Diseases Journal Issue: 9 Vol. 226; ISSN 0022-1899
- Publisher:
- Infectious Diseases Society of America
- Country of Publication:
- United States
- Language:
- English
Similar Records
Complex adenovirus-vectored vaccine protects guinea pigs from three strains of Marburg virus challenges
Delineating the mechanism of anti-Lassa virus GPC-A neutralizing antibodies
Lassa virus protein–protein interactions as mediators of Lassa fever pathogenesis
Journal Article
·
Sat Sep 30 00:00:00 EDT 2006
· Virology
·
OSTI ID:20850564
Delineating the mechanism of anti-Lassa virus GPC-A neutralizing antibodies
Journal Article
·
Tue May 24 00:00:00 EDT 2022
· Cell Reports
·
OSTI ID:1877197
Lassa virus protein–protein interactions as mediators of Lassa fever pathogenesis
Journal Article
·
Thu Feb 27 23:00:00 EST 2025
· Virology Journal
·
OSTI ID:2530823